Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-59.96	3.47	8.67
Graham Fair Price	41.43	0.24	0.17
PEG	1167.53	0.02	< 0.005
Price/Book	-16.86	0.34	0.41
Price/Cash Flow	-57.10	5.56	12.97
Prices/Earnings	-58.43	1.50	3.62
Price/Sales	-58.43	0.10	0.24
Price/FCF	-57.10	5.56	12.97
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.04	0.04
Operating Margin	1.93	0.02	0.02
ROA	100.00	0.04	0.02
ROE	0.03	0.06	100.00
ROIC	0.02	0.05	102.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.04	-0.07	-47.87
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.62	1.04	-81.54
EPS QOQ	30.00	0.98	-96.72
FCF QOQ	0.34	0.94	175.63
Revenue QOQ	-0.29	1.00	243.61
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.78	1.39	-50.00
Days Sales Outstanding (DSO)	9.64	6.10	-36.70
Inventory Turnover	32.32	64.63	100.00
Debt/Capitalization	0.17	0.17	3.19
Quick Ratio	1.51	1.67	10.58
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.22	0.22	< 0.005
Cash	0.05	0.05	-0.81
Capex	< 0.005	< 0.005	-100.02
Free Cash Flow	< 0.005	0.01	93.81
Revenue	0.36	0.73	100.02
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.30	2.30	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.98	-0.38	60.72
Naive Interpretation	Member

06 - Financial Health · Bad

Rating